Organon is a renowned global biopharmaceutical company committed to improving the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of our core therapeutic fields: fertility, gynecology and selected areas of anesthesia.

Organon India is a global company with a history of 39 years of rich experience in the Indian market.  Organon India has been headquartered in Kolkata since its inception in 1967 and currently it is headquartered in Mumbai, the commercial capital of India.

In the last three decades we have created and served Indian markets with prescription medicines that improved the health and quality of life. We have gone through the phase of multiple changes to move into the current phase of growth and expansion. 

Organon India strives to serve its customers with its products and services in the best possible way. Our envisaged growth will come from an optimal combination of organic and inorganic business opportunities.  We plan to serve the Indian market with our core therapeutic field in fertility, gynecology and selected areas of anesthesia as well as India’s specific therapeutic categories that help our customers, and in turn help the patients.

Organon’s global focus and commitment is in the pursuit of therapeutic advance which is well reflected by our 18% of annual sales devoted to Research and Development. Organon India is committed to bringing value added products coming from the pipeline of Research and Development to the Indian markets and continues to display its social commitment to the Indian customers and end users. 

At our new headquarters at Mumbai we strive to create a people driven organization with a vibrant organizational culture.  I take pleasure in inviting you to the world of Organon where we constantly expand our world.

As of November 19, 2007, Organon is now part of the American pharmaceutical company Schering-Plough. This combination holds significant promise and will allow us to build an even stronger and better company for the long-term.

Bringing together the rich histories and complementary strengths of the separate entities, we are moving forward as an innovation-driven, science-centered global health care company. Through our own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world.

With our global headquarters in Kenilworth, New Jersey, U.S.A., and a team of 50,000 highly motivated colleagues, our vision is to “Earn Trust, Every Day” with the doctors, patients, customers and other stakeholders. And, we are committed to remaining at the cutting edge of the industry as a world class provider not only of human healthcare prescription and consumer products, but also of animal health products.

This website contains information specifically about the activities of Organon. In addition to learning more about this part of the company, we invite you to visit www.schering-plough.com to find out about our other people, products and processes.